Oxidative stress-related factors in Bartter's and Gitelman's syndromes: Relevance for angiotensin II signalling

Nephrology Dialysis Transplantation

Volumn 18, Issue 8, 2003, Pages 1518-1525

  Calò, Lorenzo A ^a   Pagnin, Elisa ^a   Davis, Paul A ^b   Sartori, Michelangelo ^a   Semplicini, Andrea ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiotensin II; Atherosclerosis; Signal transduction; Vasoactive agents; Vasoconstriction dilation

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANTIOXIDANT; CALCIUM; HEME OXYGENASE 1; INOSITOL TRISPHOSPHATE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; OXIDOREDUCTASE; PEROXYNITRITE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTICLE; BARTTER SYNDROME; BINDING SITE; BLOOD VESSEL REACTIVITY; CALCIUM TRANSPORT; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBUNIT; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GITELMAN SYNDROME; HUMAN; LIPID PEROXIDATION; MALE; MONOCYTE; OXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLASMA; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS;

ADULT; ANGIOTENSIN II; BARTTER SYNDROME; FEMALE; HUMANS; MALE; MEMBRANE TRANSPORT PROTEINS; MIDDLE AGED; NADPH DEHYDROGENASE; NADPH OXIDASE; OXIDATIVE STRESS; PEROXYNITROUS ACID; PHOSPHOPROTEINS; PHOSPHORIC MONOESTER HYDROLASES; POLYMERASE CHAIN REACTION; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0037591068     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg204     Document Type: Article

References (23)

1. Calò L, Davis PA, Semplicini A. Regulation of vascular tone in Bartter's and Gitelman's syndromes. Crit Rev Clin Lab Sci 2000; 37: 503-523
2. Calò L, Cantaro S, Piccoli A, Favaro S, Bonfante L, Borsatti A. Full pattern of urinary prostaglandins in Bartter's syndrome. Nephron 1990; 56: 451-452
3. Calò L, Ceolotto G, Milani M et al. Abnormalities of Gq mediated cell signaling in Bartter's and Gitelman's syndromes. Kidney Int 2001; 60: 882-889
4. Griendling KK, Ushio-Fukai M, Lassegue B, Alexander RW. Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 1997; 29 [part 2]: 366-373
5. Dzau VJ. Tissue angiotensin and pathobiology of vascular disease. A unifying hypothesis. Hypertension 2001; 37: 1047-1052
6. Griendling KK, Soresen D, Ushio-Fukai M. NAD(P)H oxidase. Role in cardiovascular biology and disease. Circ Res 2000; 86: 494-501
7. Nath KA, Grande J, Croatt A, Haugen J, Kim Y, Rosenberg ME. Redox regulation of renal DNA synthesis, transforming growth factor-beta-1 and collagen gene expression. Kidney Int 1998; 53: 367-381
8. Abe J, Berk BC. Reactive oxygen species as mediators of signal transduction in cardiovascular disease. Trends Cardiovasc Med 1998; 8: 59-64
9. Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol 1997; 37: 517-554
10. Immenschuh S, Ramadori G. Gene regulation of heme oxygenase-1 as a therapeutic target. Biochem Pharmacol 2000; 60: 1121-1128
11. Calò L, Sartore G, Bassi A et al. Reduced susceptibility of low density lipoprotein to oxidation in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome). J Hypertens 1998; 16: 1001-1008
12. Davis PA, Calò L. Is atherosclerosis a no NO state? Circulation 1999; 20: 2709-2712
13. Bellomo G, Perrugini C, Bagnati M. Biochemical markers of lipoprotein oxidation. Clin Chem Lab Med 1998; 36: A41
14. Kaur H, Halliwell B. Evidence for nitric oxide-mediated oxidative damage in chronic inflammation. Nitrotirosine in serum and synovial fluid from rheumatoid patients. FEBS Lett 1994; 350: 9-12
15. Cahilli C, Ballantyne CM, Lim DS, Gotto A, Marian AJ. A variant of p22phox, involved in the generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res 2000; 86: 391-395
16. Zhang H, Schmeißer A, Garlichs CD et al. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH/NADPH oxidases. Cardiovasc Res 1999; 215-222.
17. Hilgers KF. Monocytes/macrophages in hypertension. J Hypertens 2002; 20: 593-596
18. Yasunari K, Maeda K, Nakamura M, Yoshikawa J. Oxidative stress in leukocytes is a possible link between blood pressure, blood glucose, and C-reacting protein. Hypertension 2002; 39: 777-780
19. Silacci P, Hayoz D. Oxidative stress as the triggering event for vascular remodelling. Nephrol Dial Transplant 1998; 13: 1343-1346
20. Basile DP. The transforming growth factor β system in kidney disease and repair: recent progress and future directions. Curr Opin Nephrol Hypertens 1999; 8: 21-30
21. Motterlini R, Foresti R, Intaglietta M, Winslow RM. NO mediated activation of heme oxygenase: endogenous cytoprotection against oxidative stress to endothelium. Am J Physiol 1996; 270: H107-H114
22. Hill-Kapturczak N, Truong L, Thamilselvan V, Visner GA, Nick HS, Agarwal A. Smad7-dependent regulation of heme oxygenase-1 by transforming growth factor-β in human renal epithelial cells. J Biol Chem 2000; 275: 40904-40909
23. Dhalla NS, Temsha RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18: 655-673